Thu, Oct 2, 2014, 12:16 PM EDT - U.S. Markets close in 3 hrs 44 mins

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • devilsyankeesfan devilsyankeesfan Apr 5, 2013 10:30 PM Flag

    I agree with Aimephil

    The increased levels of dystrophin are not really occurring. The tests being used to measure dystrophin are fake.
    Eteplirsen is not dramatically slowing the progression of the disease. This is a lie.
    Max's story is made up. He is not getting better. The McNarys are faking the whole story. They may not even have children with DMD.
    The claims of other families that eteplirsen is helping their child is nothing more than a conspiracy perpetrated by Chris and SRPT simply so they can make money. I believe they are hired actors like the McNarys.
    Dr. Mendell's claim that the 48 wk results were historic and unprecedented was laughable. Dr. Mendell is not even a doctor. He is an actor paid by Chris.
    The analysts who have given a price target that is over 100% higher than what SRPT currently trades for is nonsense.

    The only person that has realized all of this is aimephil. Therefore, i believe, like aimephil, that the FDA should continue to delay approving this drug. These children should continue to wait. Who cares if the disease continues to progress? The fact is there is no evidence whatsoever that this drug is safe or effective. I, like aimephil, not only hopes the FDA does not approve this drug but that the drug fails altogether. Who cares about these kids anyway?

    For those that are sarcasm impaired, the above was sarcasm.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
21.19-0.69(-3.15%)12:15 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.